GREEN THUMB INDS (R9U2.F) Financials
R9U2.F Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 2.5 billion | 786.8 million |
2023-09-30 | 2.5 billion | 792.3 million |
2023-06-30 | 2.5 billion | 807.0 million |
2023-03-31 | 2.5 billion | 812.0 million |
R9U2.F Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 34.7 million | 7.4 million |
2023-09-30 | 6.6 million | 7.2 million |
2023-06-30 | -46.1 million | 7.4 million |
2023-03-31 | 9.7 million | 6.2 million |
R9U2.F Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-12-31 | 3.2 million |
2023-09-30 | 10.5 million |
2023-06-30 | 13.4 million |
2023-03-31 | 9.1 million |
R9U2.F Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | - | - | 261.8 million |
2023-09-30 | - | - | 261.8 million |
2023-06-30 | - | - | 248.3 million |
2023-03-31 | - | - | 263.4 million |
R9U2.F Shares Outstanding
R9U2.F Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 36.4 million | - | 92.3 million | - |
2023-09-30 | 54.2 million | - | 84.8 million | - |
2023-06-30 | 64.4 million | - | 84.2 million | - |
2023-03-31 | 64.4 million | - | 80.5 million | - |
R9U2.F Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 278.2 million | 135.5 million |
2023-09-30 | 275.4 million | 141.6 million |
2023-06-30 | 252.4 million | 127.1 million |
2023-03-31 | 248.5 million | 123.8 million |
R9U2.F
Price: €11.24
52 week price:
Earnings Per Share: 0.14 EUR
P/E Ratio: 126.70
Exchange: FRA
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 1261
Market Capitalization: 3.2 billion